Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial

Title
Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial
Authors
Keywords
-
Journal
GYNECOLOGIC ONCOLOGY
Volume 132, Issue 1, Pages 176-180
Publisher
Elsevier BV
Online
2013-11-05
DOI
10.1016/j.ygyno.2013.10.032

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More